14-day Premium Trial Subscription Try For FreeGet Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IMGN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

ImmunoGen stock upgraded from Hold/Accumulate to Buy Candidate after Friday trading session.
(Updated on Dec 01, 2023)


Buy or Hold candidate since Nov 24, 2023 Gain 82.57% PDF
The ImmunoGen stock price fell by -0.102% on the last day (Friday, 1st Dec 2023) from $29.35 to $29.32. During the last trading day the stock fluctuated 1.42% from a day low at $28.94 to a day high of $29.35. The price has risen in 6 of the last 10 days and is up by 88.07% over the past 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -37 million shares and in total, 30 million shares were bought and sold for approximately $883.14 million.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

The stock lies in the upper part of a very wide and weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $29.39 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 9.95% during the next 3 months and, with a 90% probability hold a price between $15.02 and $32.32 at the end of this 3-month period.

IMGN Signals & Forecast

The ImmunoGen stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $19.87 and $15.92. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, November 30, 2023, and so far it has fallen -0.102%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Get your hands on a piece of history – invest in multi-million dollar paintings from $10k with Masterworks.

Support, Risk & Stop-loss for ImmunoGen stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.410 between high and low, or 1.42%. For the last week, the stock has had daily average volatility of 3.10%.

The ImmunoGen stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.

Our recommended stop-loss: $28.38 (-3.22%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 91 and this increases the risk substantially. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (IMGN) For The Upcoming Trading Day Of Monday 4th

For the upcoming trading day on Monday, 4th we expect ImmunoGen to open at $29.20, and during the day (based on 14 day Average True Range), to move between $27.69 and $30.95, which gives a possible trading interval of +/-$1.63 (+/-5.55%) up or down from last closing price. If ImmunoGen takes out the full calculated possible swing range there will be an estimated 11.09% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $29.35, some $0.0300 (0.10%) from the current price of $29.32, our system finds the risk reward not very attractive.

Is ImmunoGen stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for ImmunoGen stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 2.216 Open Broker Account

Buy Candidate Upgraded

Predicted Opening Price for ImmunoGen of Monday, December 4, 2023

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Fair opening price December 4, 2023 Current price
$29.20 $29.32 (Overvalued)

Remember To Visit Our YouTube Channel


Fibonacci Support & Resistance Levels

Level Price
Resistance R3 29.61 1.00 %
R2 29.46 0.466 %
R1 29.36 0.136 %
Current price: 29.32
Support S1 29.05 -0.93 %
S2 28.95 -1.26 %
S3 28.79 -1.80 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 29.35 0.102 %
Current price 29.32
Support S1 0 .
S2 0 .
S3 0 .
What is the symbol for ImmunoGen Stock and on which exchange is it traded?
The symbol for ImmunoGen is IMGN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ImmunoGen Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for ImmunoGen stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy ImmunoGen Stock?
ImmunoGen Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ImmunoGen Stock.

What's the current price of ImmunoGen Stock?
As of the end of day on the 2023-12-01, the price of an ImmunoGen (IMGN) share was $29.32.

What is the 52-week high and low for ImmunoGen Stock?
The 52-week high for ImmunoGen Stock is $29.44 and the 52-week low is $3.61.

What is the market capitalization of ImmunoGen Stock?
As of the 2023-12-01, the market capitalization of ImmunoGen is 7.815B.

When is the next earnings date for ImmunoGen?
The upcoming earnings date for ImmunoGen is 2024-03-06 00:00:00.

Click to get the best stock tips daily for free!

About ImmunoGen

ImmunoGen ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and... IMGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT